The newly revealed cases all occurred in people before the government’s 11-day pause in J&J’s single-dose vaccine last month.
Author: Karen Weintraub, USA TODAY
Pfizer-BioNTech seeks full FDA approval for COVID-19 vaccine
Like other vaccines available in the U.S., Pfizer-BioNTech have been providing their vaccine under an emergency use authorization.
Pfizer vaccine for adolescents to get FDA authorization; much-anticipated decision opens door for teens 12-15
The Food and Drug Administration is likely to authorize the Pfizer-BioNTech COVID-19 vaccine for adolescents within the next week, according to the New York Times and CNN.
An experimental gene therapy was little Alissa’s only hope. Now, instead of certain death, she faces an uncertain future.
A scientific vision for decades, gene therapy is finally becoming more common in the U.S., fueling optimism for the treatment of rare diseases.
‘Like somebody gave me a happy pill:’ Monoclonal antibodies are helping the Americans most at risk for COVID-19
The therapy can be life-saving, especially in the early stages of an infection, and it’s becoming easier to access across the US.
COVID-19 vaccine from AstraZeneca-Oxford slightly less effective than first touted: 76% rather than 79% against disease, updated data shows
More recent clinical trial results show AstraZeneca’s COVID-19 vaccine is slightly less effective in stopping disease than the company first reported.
Moncef Slaoui, former Operation Warp Speed science chief, fired by drugmaker GSK for sexual harassment
Moncef Slaoui, a former head of Operation Warp Speed, who spearheaded COVID-19 vaccine development in the USA, was fired by GSK for harassing an employee.
FDA advisory committees will begin hearings on drug aimed at osteoarthritis pain
Two FDA advisory committees will begin meeting Wednesday on a Pfizer drug called tanezumab that could bring relief for osteoarthritis pain.
‘It’s easy to scare people’: Europe’s decision to pull AstraZeneca-Oxford vaccine threatens global COVID-19 recovery efforts, US experts say
As AstraZeneca defends its COVID-19 vaccine following a European pause, the World Health Organization says there is no reason to stop using it.
‘We need to be prepared’: FDA will draft guidance to work with vaccine, drug and testing companies on COVID-19 variants
FDA plans to develop guidance to help COVID-19 vaccine, drug and testing manufacturers adapt to emerging variants of the SARS-CoV-2 virus.